Skip to main content
Mochida Pharmaceutical Co.,Ltd. logo

Mochida Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 4534 ISIN · JP3922800002 LEI · 3538008YGVRYRM8B7Q95 T Manufacturing
Open in API
Filings indexed 58 across all filing types
Latest filing 2025-11-10 Report Publication Anno…
Country JP Japan
Listing T 4534

About Mochida Pharmaceutical Co.,Ltd.

https://www.mochida.co.jp/english/

Mochida Pharmaceutical Co., Ltd. is a research-driven company focused on the development, manufacturing, and sale of pharmaceuticals, healthcare products, and medical devices. The company's core pharmaceutical business concentrates on therapeutic areas such as cardiovascular diseases, with a key focus on circulatory agents. It is also active in other fields, including oncology, through partnerships for generic products. In its healthcare segment, Mochida develops and markets functional, low-irritating products based on dermatological science. Additionally, the company distributes medical instruments and equipment for diagnostic and surgical applications, contributing to a broad spectrum of medical care.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically confirming the accuracy of the contents of a Semi-Annual Report (Interim Report) for the period ending September 30, 2025. Since this is a regulatory filing required by law to accompany the financial report but is not the financial report itself, and does not fit into specific categories like 'Annual Report' or 'Interim Report', it falls under the 'Regulatory Filings' (RNS) category as a miscellaneous regulatory document.
2025-11-10 Japanese
半期報告書－第88期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Mochida Pharmaceutical Co., Ltd. with the Kanto Local Finance Bureau. It contains comprehensive financial statements, including the balance sheet, for the interim period (April 1, 2025, to September 30, 2025). It is a formal regulatory filing under the Financial Instruments and Exchange Act, which corresponds to the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-10 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report) and explicitly states in Section 1 ('提出理由') that it is being submitted because resolutions were passed at the '第87回定時株主総会' (87th Annual General Meeting) held on June 27, 2025. Section 2 ('報告内容') details the resolutions, including dividend approval, director elections, and approval of the anti-takeover defense policy. The core content is the official results of shareholder voting ('決議の結果'). This structure perfectly matches the definition of reporting the results of a general meeting vote. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-07-01 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is extremely short (586 characters) and contains a table structure typical of a cover page for a regulatory filing in Japan. Key elements include: "【提出書類】確認書" (Filing Document: Confirmation Document), "【根拠条文】金融商品取引法第24条の4の2第1項" (Basis Article: Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act), and confirmation by the CEO regarding the appropriateness of the '有価証券報告書' (Annual Securities Report, equivalent to 10-K). Since this document is merely a 'Confirmation Document' (確認書) affirming the accuracy of the underlying Annual Securities Report (10-K) rather than the full 10-K itself, and given its brevity, it functions as an ancillary regulatory filing or a specific declaration related to the main report. It is not a full 10-K, ER, or IR. It is a specific declaration/confirmation related to the annual filing, which fits best under the general 'Regulatory Filings' (RNS) category as a specific declaration, or potentially an Audit Report/Information (AR) if it were an auditor's confirmation, but here it is management's confirmation. Given the options, RNS is the most appropriate fallback for a specific, short regulatory declaration that isn't a primary financial report or a standard announcement like DIV or DIRS. FY 2025
2025-06-27 Japanese
内部統制報告書－第87期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法). The content discusses the framework, scope, criteria, and conclusion regarding the assessment of internal controls over financial reporting as of the fiscal year-end (March 31, 2025). This structure is characteristic of an annual internal control report, which is often filed alongside the 10-K in Japan, but based on the provided definitions, it most closely aligns with an Audit Report/Information (AR) as it deals with internal controls and assessment standards, rather than being the full Annual Report (10-K) itself, or a specific management discussion (MDA). However, given the specific nature of 'Internal Control Report' in the Japanese regulatory context, which is a mandatory annual filing focusing on internal controls, it is a specialized report. Since 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)', this document fits well under this category as it is a formal report on internal control assessment standards and results. It is not an Earnings Release (ER), Interim Report (IR), or a general Audit Report (AR) in the Western sense, but it is a formal, comprehensive annual report on a specific control aspect.
2025-06-27 Japanese
有価証券報告書－第87期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K. It contains a formal header identifying it as a filing under the Financial Instruments and Exchange Act, covering a full fiscal year (2024-04-01 to 2025-03-31), and includes extensive XBRL-tagged financial data. It is a comprehensive annual report, not an announcement or a summary. FY 2025
2025-06-27 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.